Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bacterial 50S ribosomal subunit 23S rRNA peptidyl transferase center (PTC) A-site is the primary functional locus within the large ribosomal subunit responsible for decoding and peptide bond formation (Polikanov et al., 2014, Molecular Cell, https://doi.org/10.1016/j.molcel.2014.09.020). It serves as the entry point for aminoacyl-tRNA molecules, which must correctly position their amino acid cargo for the peptidyl transferase reaction catalyzed by the 23S rRNA ribozyme (Wilson, 2014, Cold Spring Harbor Perspectives in Biology, https://doi.org/10.1101/cshperspect.a017954). This site is a critical target for several classes of antibiotics, including oxazolidinones, pleuromutilins, and phenicols, which disrupt bacterial growth by inhibiting protein synthesis (Eyal et al., 2015, Scientific Reports, https://doi.org/10.1038/srep16699). These drugs typically bind to the A-site or the A-site/P-site interface, sterically hindering the accommodation of tRNA or interfering with the catalytic environment (Long et al., 2006, Antimicrobial Agents and Chemotherapy, https://doi.org/10.1128/AAC.00658-06). Clinical challenges include the emergence of resistance through 23S rRNA mutations or enzymatic modification by Cfr methyltransferases, as well as potential host toxicity due to the structural homology between bacterial and human mitochondrial ribosomes (Leach et al., 2007, Molecular Pharmacology, https://doi.org/10.1124/mol.106.030015).
Inhibition of bacterial protein synthesis by sterically blocking the binding of aminoacyl-tRNA to the A-site or by interfering with the catalytic environment required for the peptidyl transferase reaction.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 50S ribosomal subunit 23S rRNA peptidyl transferase center A-site (PTC A-site).